» Articles » PMID: 29330379

Identification of Shared Genetic Variants Between Schizophrenia and Lung Cancer

Abstract

Epidemiology studies suggest associations between schizophrenia and cancer. However, the underlying genetic mechanisms are not well understood, and difficult to identify from epidemiological data. We investigated if there is a shared genetic architecture between schizophrenia and cancer, with the aim to identify specific overlapping genetic loci. First, we performed genome-wide enrichment analysis and second, we analyzed specific loci jointly associated with schizophrenia and cancer by the conjunction false discovery rate. We analyzed the largest genome-wide association studies of schizophrenia and lung, breast, prostate, ovary, and colon-rectum cancer including more than 220,000 subjects, and included genetic association with smoking behavior. Polygenic enrichment of associations with lung cancer was observed in schizophrenia, and weak enrichment for the remaining cancer sites. After excluding the major histocompatibility complex region, we identified three independent loci jointly associated with schizophrenia and lung cancer. The strongest association included nicotinic acetylcholine receptors and is an established pleiotropic locus shared between lung cancer and smoking. The two other loci were independent of genetic association with smoking. Functional analysis identified downstream pleiotropic effects on epigenetics and gene-expression in lung and brain tissue. These findings suggest that genetic factors may explain partly the observed epidemiological association of lung cancer and schizophrenia.

Citing Articles

The causal relationship between severe mental illness and risk of lung carcinoma.

Chen X, Wang S, Shen W Medicine (Baltimore). 2024; 103(11):e37355.

PMID: 38489734 PMC: 10939700. DOI: 10.1097/MD.0000000000037355.


Genetic prediction of the causal relationship between schizophrenia and tumors: a Mendelian randomized study.

Zhou X, Liu Q, Liu S, Wang L, Sun Z, Sun C Front Oncol. 2024; 14:1321445.

PMID: 38434685 PMC: 10905381. DOI: 10.3389/fonc.2024.1321445.


Recent natural selection conferred protection against schizophrenia by non-antagonistic pleiotropy.

Gonzalez-Penas J, de Hoyos L, Diaz-Caneja C, Andreu-Bernabeu A, Stella C, Gurriaran X Sci Rep. 2023; 13(1):15500.

PMID: 37726359 PMC: 10509162. DOI: 10.1038/s41598-023-42578-0.


Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment?.

Hamoud A, Bach K, Kakrecha O, Henkel N, Wu X, McCullumsmith R Int J Mol Sci. 2022; 23(19).

PMID: 36233136 PMC: 9570456. DOI: 10.3390/ijms231911835.


Case report: Schizophrenia and hypertrophic osteoarthropathy, a rare syndrome hiding a life-threatening condition.

Baklouti E, Karoui M, Kammoun R, Ellouze F Clin Case Rep. 2022; 10(1):e05247.

PMID: 35059198 PMC: 8755596. DOI: 10.1002/ccr3.5247.


References
1.
Albert F, Kruglyak L . The role of regulatory variation in complex traits and disease. Nat Rev Genet. 2015; 16(4):197-212. DOI: 10.1038/nrg3891. View

2.
. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010; 42(5):441-7. PMC: 2914600. DOI: 10.1038/ng.571. View

3.
Tran E, Rouillon F, Loze J, Casadebaig F, Philippe A, Vitry F . Cancer mortality in patients with schizophrenia: an 11-year prospective cohort study. Cancer. 2009; 115(15):3555-62. DOI: 10.1002/cncr.24383. View

4.
Ramasamy A, Trabzuni D, Guelfi S, Varghese V, Smith C, Walker R . Genetic variability in the regulation of gene expression in ten regions of the human brain. Nat Neurosci. 2014; 17(10):1418-1428. PMC: 4208299. DOI: 10.1038/nn.3801. View

5.
. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. PMC: 4112379. DOI: 10.1038/nature13595. View